Study to Evaluate the Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel (CTEV) in Patients With Coronary Artery Disease Requiring Coronary Artery Bypass Grafting (CABG)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Related studies linked through entity extraction aliases.